| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.64 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |